Burcon NutraScience

Burcon NutraScience is a Canada corporation that develops plant proteins and ingredients for use in the food and beverage industries. The company's products include CLARISOY, a soy protein for use in sports nutrition beverages, dairy alternative yogurts and other foods and nutritional products; and Peazazz, a pea protein for dairy alternative products. Burcon NutraScience was founded in 1998 and is headquartered in Vancouver, Canada.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Burcon NutraScience balance sheet

Report period2017 2018 2019 2020 2021 Q3 22
End date of the reporting period
Capitalization, С$
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Burcon NutraScience cash flows

Report period2017 2018 2019 2020 2021 Q3 22 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Burcon NutraScience multipliers

Report period2017 2018 2019 2020 2021 Q3 22 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Burcon NutraScience profitability

Report period2017 2018 2019 2020 2021 Q3 22 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Burcon NutraScience assets
Burcon NutraScience cash flows

Burcon NutraScience dividend policy

The company doesn't provide dividend
Burcon NutraScience news
02.09.2022
Burcon NutraScience's board of directors has finally concluded that it is inadvisable to spend resources to restore compliance with Nasdaq listing requirements. The company has notified the exchange of the delisting of the stock. The securities will cease trading on or about September 12.
Source: {source} pictogram burcon.ca
Pictogram next
28.06.2022
Burcon NutraScience's IFRS loss for fiscal year 2022 was C$10.258 million, up 16.6 times from C$0.618 million in the previous year. Revenues fell 33.7% to C$171,471 thousand from C$258,646 thousand a year earlier.
Source: {source} pictogram burcon.ca
Pictogram next
15.02.2022
Burcon NutraScience's IFRS loss for 9 months of fiscal year 2022 was C$6.042 million, compared to a loss of C$1.89 million in the previous year. Revenue increased 10.9 times to C$94.222 million from C$8.646 million a year earlier.
Source: {source} pictogram burcon.ca
Pictogram next
16.11.2021
Burcon NutraScience' IFRS loss for 6M 2022 fiscal year was C$4.535 million, compared to a profit of C$2.977 million in the previous year. Royalty income increased 5.7 times to C$49,625k from C$8,646k a year earlier.
Source: {source} pictogram burcon.ca
Pictogram next
All Burcon NutraScience news
General information
Company nameBurcon NutraScience
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address1946 West Broadway Vancouver, BC V6J 1Z2 Canada
Mailing address1946 West Broadway Vancouver, BC V6J 1Z2 Canada
Websiteburcon.ca
Information disclosurewww.sec.gov